Lorcaserin
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Pharmacokinetics in Obese Adolescents
Conditions
Pharmacokinetics in Obese Adolescents
Trial Timeline
Dec 1, 2013 → —
NCT ID
NCT02022956About Lorcaserin
Lorcaserin is a phase 1 stage product being developed by Eisai for Pharmacokinetics in Obese Adolescents. The current trial status is completed. This product is registered under clinical trial identifier NCT02022956. Target conditions include Pharmacokinetics in Obese Adolescents.
What happened to similar drugs?
5 of 5 similar drugs in Pharmacokinetics in Obese Adolescents were approved
Approved (5) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (5)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04457687 | Pre-clinical | Active |
| NCT03552107 | Pre-clinical | Completed |
| NCT02022956 | Phase 1 | Completed |
| NCT00828581 | Phase 1 | Completed |
| NCT00828932 | Phase 1 | Completed |
Competing Products
20 competing products in Pharmacokinetics in Obese Adolescents